Pharmaceutical companies fined for hydrocortisone overcharging

16 Jul 2021


The UK Competition and Markets Authority has fined the manufacturers of hydrocortisone for inflating the cost of the life-saving medication by over 10,000% in the last decade

Guardian


Related Topics

Steroid and Steroidogenesis

Share this story